Dear Editor

Corynebacteria are aerobic, non-spore forming, and gram-positive bacilli that are commensal organisms of skin and mucosal membranes. *C. striatum*, like other *Corynebacterium* species, is a part of the normal human skin flora; therefore, it has been frequently dismissed as a blood and airway sample contaminant in the past. However, *C. striatum* is emerging as a cause of bloodstream infections and endocarditis \[[@B1]\]. Moreover, *C. striatum* infection outbreaks have been reported in long-stay patients with underlying disease \[[@B2]\]. We report a case of *C. striatum* bacteremia in a patient who had undergone gastrostomy. To our knowledge, there has been no report of *C. striatum* bacteremia in Korea so far.

A 64-yr-old quadriplegic man visited the outpatient rehabilitation clinic for gastrostomy tube change. Before visiting our hospital, he was admitted to a secondary hospital and had hypertension and diabetes mellitus. Nine months before this visit, quadriplegia developed because of hypoxic ischemic encephalopathy; he underwent tracheostomy and gastrostomy tube placement. He was admitted to our hospital owing to persistent low-grade fever with blood pressure of 156/89 mmHg. The white blood cell count was 6.02×10^9^/L (86% segmented neutrophils), and C-reactive protein level was 3.34 mg/dL (reference range: \<0.30 mg/dL). Three aerobic and anaerobic blood culture sets were incubated in the BacT/Alert 3D system (bioMérieux, Durham, NC, USA). Bacterial growth after 24-hr incubation was noted in three anaerobic culture bottles. The organism was gram-positive diphtheroid type rod and was identified as *C. striatum* by VITEK 2 (bioMérieux, Marcy l\'Etoile, France) anaerobic & corynebacteria identification system (% probability: 99%, confidence level: excellent identification) that was confirmed by 16S rRNA sequencing. All sequences were analyzed by using the basic local alignment search tool (BLAST) and ribosomal database project. Minimal inhibitory concentration (MIC) was determined by using broth microdilution in cation-adjusted Mueller-Hinton broth with lysed horse blood according to the CLSI guidelines \[[@B3]\]. The organism was susceptible to vancomycin (MIC 0.5 µg/mL) and trimethoprim/sulfamethoxazole (2/38 µg/mL), but it was resistant to penicillin (8 µg/mL), cefotaxime (4 µg/mL), ceftriaxone (4 µg/mL), cefepime (4 µg/mL), tetracycline (64 µg/mL), clindamycin (\>128 µg/mL), and erythromycin (\>128 µg/mL).

At first, the physician assumed that *C. striatum* was a contaminant and the fever was caused by a urinary tract infection on the basis of the past history. Thus, only intravenous piperacillin/tazobactam was administered for the possible urinary tract infection. Culture for medical devices such as the gastrostomy or tracheostomy tubes was not performed. However, fever did not subside and C-reactive protein level was elevated; follow-up blood cultures performed on the 6th day of admission revealed *C. striatum* growth. The patient was continuously given intravenous piperacillin/tazobactam. As the fever subsided, he was transferred to a provincial medical center. The patient was readmitted for check-up a month after discharge and showed no sign of infection.

It is difficult to distinguish simple colonization from real infection when *Corynebacterium* spp. are recovered from specimens \[[@B4]\]. *C. striatum* are commonly isolated in patients with significant underlying illnesses \[[@B2]\] and has close association with various medical devices such as prosthetic valve/joint and central venous catheter \[[@B5]\] and long hospitalization.

In this case, the patient suffered from diabetes, hypertension, tracheostomy, and gastrostomy. Additionally, he had stayed at a secondary health care center before being admitted to our hospital. These factors probably increased the patient\'s risk of *C. striatum* infection. Additionally, each of the blood culture sets was collected at regularly spaced intervals with adequate blood volumes, and turned positive within 24 hr. One of the recent issues related to *C. striatum* is the emergence and spread of multidrug resistance. Generally, most of the reported *C. striatum* isolates were susceptible to a wide range of antibiotics \[[@B6]\]; however, recent studies showed the emergence of multi-drug resistant strains with increasing use of broad-spectrum antibiotics ([Table 1](#T1){ref-type="table"}) \[[@B1], [@B4], [@B6], [@B7]\]. When invasive *C. striatum* infection is suspected, most initial therapies should include vancomycin, because *in vitro* resistance to vancomycin has not been reported in any of the *Corynebacterium* species \[[@B5]\]. If the patient is allergic to vancomycin, daptomycin may be an alternative. Fernandez *et al*. \[[@B1]\] reported successful treatment of a case of multidrug-resistant *C. striatum* endocarditis with daptomycin.

In conclusion, with increasing numbers of immunosuppressed patients and indwelling medical devices, *C. striatum* infections will be more commonly found and should never be overlooked as a contaminant. This report suggests the need to increase awareness of *C. striatum* as a pathogen causing bloodstream infections.
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###### Multidrug resistant *Corynebacterium striatum* in the literature
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  Antimicrobials   Antimicrobial susceptibility results of *C. striatum*                      
  ---------------- ------------------------------------------------------- ---- -------- ---- ----
  Penicillin       R                                                       R    R        R    R
  Cefotaxime       R                                                       R    \-^\*^   \-   \-
  Ceftriaxone      R                                                       R    \-       \-   \-
  Cefepime         R                                                       R    \-       \-   \-
  Tetracycline     R                                                       \-   R        R    R
  Clindamycin      R                                                       R    R        \-   R
  Erythromycin     R                                                       \-   R        R    R
  Vancomycin       S                                                       S    S        S    S
  TMP/SMX          S                                                       R    R        \-   R

^\*^Not documented.

Abbreviations: R, resistant; S, susceptible; TMP/SMX, trimethoprim/sulfamethoxazole.
